Manish Tewari asks Punjab CM to oppose MHA notification enhancing BSF mandate
Darpan News Desk IANS, 13 Oct, 2021 11:06 AM
New Delhi, Oct 13 (IANS) Congress MP from Anandpur Sahib Manish Tewari on Wednesday asked Punjab Chief Minister Charanjit Channi to oppose the Ministry of Home Affairs notification for enhancement of the Border Security Force operational mandate in Punjab.
Manish Tewari said in a tweet ,"MHA Notification enhancing operational mandate of BSF, 15 to 50 KM's in Punjab, West Bengal & Assam transgresses upon Constitutional Public order & Policing remit of States Half of Punjab will now fall under BSF jurisdiction @CHARANJITCHANNI must oppose it ".
As per reports, the notification issued this week by the MHA extends the operational mandate where the BSF has powers of search, seizure and arrest under the NDPS Act, Customs Act and Passport Act to a 50 km-belt in some states including Punjab.
Tewari added that, "Mischievous part of Section 139 of BSF Act or of any cognizable offence punishable under any other Central Act; ..'It allows GOI to institutionalise an alternative policing paradigm. Was Punjab Govt consulted?"
Section 139 of the Border Security Force Act, 1968, empowers the Centre to notify the area and extent of the border force's operational mandate, from time to time.
The addition of an extra 35-km stretch to the BSF's mandate could lead to a political storm in Punjab and Bengal which are ruled by non-BJP parties. The Congress leaders from Punjab are the first to oppose the move.
A huge milestone for an Indian Air Force member. Dalip Singh Majithia, celebrated his 100th birthday on Monday making him the oldest living IAF fighter pilot.
Spokesperson Anurag Srivastava with the Ministry of External Affiars in India has started a protest with the Pakistan High Commission over alleged attempts to convert a Pakistant gurdwara into a mosque.
After UK broke the news that they have a vaccine that can trigger an immune response, India isn't far behind. India's first coronavirus vaccine COVAXIN human trials are in full swing Monday at the All India Institute of Medical Science (AIIMS), Delhi after its Ethics Committee gave it the go ahead.
